• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Beow Yong Yeap, ScD

Publications

  • Hong TS, Ryan DP, Borger DR, Blaszkowsky LS, Yeap BY, Ancukiewicz M, Deshpande V, Shinagare S, Wo JY, Boucher Y, Wadlow RC, Kwak EL, Allen JN, Clark JW, Zhu AX, Ferrone CR, Mamon HJ, Adams J, Winrich B, Grillo T, Jain RK, DeLaney TF, Fernandez-Del Castillo C, Duda DG.A Phase 1/2 and Biomarker Study of Preoperative Short Course Chemoradiation With Proton Beam Therapy and Capecitabine Followed By Early Surgery for Resectable Pancreatic Ductal Adenocarcinoma.Int J Radiat Oncol Biol Phys. 2014 May 24.
    24867540
  • Delaney TF, Liebsch NJ, Pedlow FX, Adams J, Weyman EA, Yeap BY, Depauw N, Nielsen GP, Harmon DC, Yoon SS, Chen YL, Schwab JH, Hornicek FJ.Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas.J Surg Oncol. 2014 Apr 19.
    24752878
  • Yeh AC, Brunner AM, Spitzer TR, Chen YB, Coughlin E, McAfee S, Ballen K, Attar E, Caron M, Preffer FI, Yeap BY, Dey BR.Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation.Biol Blood Marrow Transplant. 2014 May;20(5):730-4.
    24530972
  • De Rienzo A, Yeap BY, Cibas ES, Richards WG, Dong L, Gill RR, Sugarbaker DJ, Bueno R.Gene expression ratio test distinguishes normal lung from lung tumors in solid tissue and FNA biopsies.J Mol Diagn. 2014 Mar;16(2):267-72.
    24412526
  • Chirieac LR, Barletta JA, Yeap BY, Richards WG, Tilleman T, Bueno R, Baldini EH, Godleski J, Sugarbaker DJ.Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma.J Clin Oncol. 2013 Dec 20;31(36):4544-9.
    24248693
  • Sethi RV, Shih HA, Yeap BY, Mouw KW, Petersen R, Kim DY, Munzenrider JE, Grabowski E, Rodriguez-Galindo C, Yock TI, Tarbell NJ, Marcus KJ, Mukai S, MacDonald SM.Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy.Cancer. 2014 Jan 1;120(1):126-33.
    24122173
  • Burt BM, Ali SO, DaSilva MC, Yeap BY, Richards WG, Baldini EH, Sugarbaker DJ.Clinical indications and results after chest wall resection for recurrent mesothelioma.J Thorac Cardiovasc Surg. 2013 Dec;146(6):1373-9; discussion 1379-80.
    24113019
  • Macdonald SM, Sethi R, Lavally B, Yeap BY, Marcus KJ, Caruso P, Pulsifer M, Huang M, Ebb D, Tarbell NJ, Yock TI.Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients.Neuro Oncology. 2013 Nov;15(11):1552-9.
    24101739
  • Mullen JT, DeLaney TF, Rosenberg AE, Le L, Iafrate AJ, Kobayashi W, Szymonifka J, Yeap BY, Chen YL, Harmon DC, Choy E, Yoon SS, Raskin KA, Hornicek FJ, Nielsen GP.β-Catenin mutation status and outcomes in sporadic desmoid tumors.Oncologist. 2013;18(9):1043-9.
    23960186
  • Cardarella S, Ogino A, Nishino M, Butaney M, Shen J, Lydon C, Yeap BY, Sholl LM, Johnson BE, Jänne PA.Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.Clin Cancer Res. 2013 Aug 15;19(16):4532-40.
    23833300
  • Gainor JF, Varghese AM, Ou SH, Kabraji S, Awad MM, Katayama R, Pawlak A, Mino-Kenudson M, Yeap BY, Riely GJ, Iafrate AJ, Arcila ME, Ladanyi M, Engelman JA, Dias-Santagata D, Shaw AT.ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer.Clin Cancer Res. 2013 Aug 1;19(15):4273-81.
    23729361
  • Gray PJ, Paly JJ, Yeap BY, Sanda MG, Sandler HM, Michalski JM, Talcott JA, Coen JJ, Hamstra DA, Shipley WU, Hahn SM, Zietman AL, Bekelman JE, Efstathiou JA.Patient-reported outcomes after 3-dimensional conformal, intensity-modulated, or proton beam radiotherapy for localized prostate cancer.Cancer. 2013 May 1;119(9):1729-35.
    23436283
  • De Rienzo A, Richards WG, Yeap BY, Coleman MH, Sugarbaker PE, Chirieac LR, Wang YE, Quackenbush J, Jensen RV, Bueno R.Sequential Binary Gene Ratio Tests Define a Novel Molecular Diagnostic Strategy for Malignant Pleural Mesothelioma.Clin Cancer Res. 2013 Apr 18.
    23493352
  • De Amorim Bernstein K, Sethi R, Trofimov A, Zeng C, Fullerton B, Yeap BY, Ebb D, Tarbell NJ, Yock TI, Macdonald SM.Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors.Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):114-20.
    23498870
  • Macdonald SM, Patel SA, Hickey S, Specht M, Isakoff SJ, Gadd M, Smith BL, Yeap BY, Adams J, Delaney TF, Kooy H, Lu HM, Taghian AG.Proton Therapy for Breast Cancer After Mastectomy: Early Outcomes of a Prospective Clinical Trial.Int J Radiat Oncol Biol Phys. 2013 Mar 21.
    23523326
  • Sugarbaker DJ, Gill RR, Yeap BY, Wolf AS, DaSilva MC, Baldini EH, Bueno R, Richards WG.Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.J Thorac Cardiovasc Surg. 2013 Apr;145(4):955-63.
    23434448
  • Santamaria-Barria JA, Boland GM, Yeap BY, Nardi V, Dias-Santagata D, Cusack JC.Merkel cell carcinoma: 30-year experience from a single institution.Ann Surg Oncol. 2013 Apr;20(4):1365-73.
    23208132
  • Gaughan EM, Cryer SK, Yeap BY, Jackman DM, Costa DB.Family history of lung cancer in never smokers with non-small-cell lung cancer and its association with tumors harboring EGFR mutations.Lung Cancer. 2013 Mar;79(3):193-7.
    23273562
  • Cardarella S, Ortiz TM, Joshi VA, Butaney M, Jackman DM, Kwiatkowski DJ, Yeap BY, Jänne PA, Lindeman NI, Johnson BE.The introduction of systematic genomic testing for patients with non-small-cell lung cancer.J Thorac Oncol. 2012 Dec;7(12):1767-74.
    23154547
  • Nishino M, Klepeis VE, Yeap BY, Bergethon K, Morales-Oyarvide V, Dias-Santagata D, Yagi Y, Mark EJ, Iafrate AJ, Mino-Kenudson M.Histologic and cytomorphologic features of ALK-rearranged lung adenocarcinomas.Mod Pathol. 2012 Nov;25(11):1462-72.
    22743652
  • Onozato ML, Kovach AE, Yeap BY, Morales-Oyarvide V, Klepeis VE, Tammireddy S, Heist RS, Mark EJ, Dias-Santagata D, Iafrate AJ, Yagi Y, Mino-Kenudson M.Tumor Islands in Resected Early-stage Lung Adenocarcinomas are Associated With Unique Clinicopathologic and Molecular Characteristics and Worse Prognosis.Am J Surg Pathol. 2012 Oct 19.
    23095504
  • Hong NJ, Hornicek FJ, Harmon DC, Choy E, Chen YL, Yoon SS, Nielsen GP, Szymonifka J, Yeap BY, Delaney TF, Mullen JT.Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: A 10-year single institution retrospective study.Eur J Cancer. 2012 Oct 20.
    23092789
  • Wang H, Yang Y, Wang G, Wang S, Yeap BY, Sykes M, Yang YG.Donor bone marrow-derived T cells inhibit GVHD induced by donor lymphocyte infusion in established mixed allogeneic hematopoietic chimeras.PLoS ONE. 2012;7(10):e47120.
    23077554
  • Mullen JT, Delaney TF, Kobayashi WK, Szymonifka J, Yeap BY, Chen YL, Rosenberg AE, Harmon DC, Choy E, Yoon SS, Raskin KA, Petur Nielsen G, Hornicek FJ.Desmoid Tumor: Analysis of Prognostic Factors and Outcomes in a Surgical Series.Ann Surg Oncol. 2012 Sep 11.
    22965569
  • Heon S, Yeap BY, Lindeman NI, Joshi VA, Butaney M, Britt GJ, Costa DB, Rabin MS, Jackman DM, Johnson BE.The impact of initial gefitinib or erlotinib versus chemotherapy on central nervous system progression in advanced non-small cell lung cancer with EGFR mutations.Clin Cancer Res. 2012 Aug 15;18(16):4406-14.
    22733536
  • Look Hong NJ, Hornicek FJ, Raskin KA, Yoon SS, Szymonifka J, Yeap B, Chen YL, Delaney TF, Nielsen GP, Mullen JT.Prognostic Factors and Outcomes of Patients with Myxofibrosarcoma.Ann Surg Oncol. 2012 Aug 14.
    22890594
  • Kuhlthau KA, Pulsifer MB, Yeap BY, Rivera Morales D, Delahaye J, Hill KS, Ebb D, Abrams AN, Macdonald SM, Tarbell NJ, Yock TI.Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy.J Clin Oncol. 2012 Jun 10;30(17):2079-86.
    22565004
  • Lutton BV, Cho PS, Hirsh EL, Ferguson KK, Teague AG, Hanekamp JS, Chi N, Goldman SN, Messina DJ, Houser S, Yeap BY, Popma SH, Sachs DH, Huang CA.Approaches to avoid immune responses induced by repeated subcutaneous injections of allogeneic umbilical cord tissue-derived cells.Transplantation. 2010 Sep 15;90(5):494-501.
    21451445
  • Childs SK, Kozak KR, Friedmann AM, Yeap BY, Adams J, Macdonald SM, Liebsch NJ, Tarbell NJ, Yock TI.Proton Radiotherapy for Parameningeal Rhabdomyosarcoma: Clinical Outcomes and Late Effects.Int J Radiat Oncol Biol Phys. 2011 Mar 4.
    21377294
  • De Rienzo A, Dong L, Yeap BY, Jensen RV, Richards WG, Gordon GJ, Sugarbaker DJ, Bueno R.Fine-needle aspiration biopsies for gene expression ratio-based diagnostic and prognostic tests in malignant pleural mesothelioma.Clin Cancer Res. 2011 Jan 15;17(2):310-6.
    21088255
  • Hong TS, Ryan DP, Blaszkowsky LS, Mamon HJ, Kwak EL, Mino-Kenudson M, Adams J, Yeap B, Winrich B, Delaney TF, Fernandez-Del Castillo C.Phase I Study of Preoperative Short-Course Chemoradiation with Proton Beam Therapy and Capecitabine for Resectable Pancreatic Ductal Adenocarcinoma of the Head.Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):151-7.
    20421151
  • Heon S, Yeap BY, Britt GJ, Costa DB, Rabin MS, Jackman DM, Johnson BE.Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinib.Clin Cancer Res. 2010 Dec 1;16(23):5873-82.
    21030498
  • Nishino M, Jackman DM, Hatabu H, Yeap BY, Cioffredi LA, Yap JT, Jänne PA, Johnson BE, Van den Abbeele AD.New Response Evaluation Criteria in Solid Tumors (RECIST) guidelines for advanced non-small cell lung cancer: comparison with original RECIST and impact on assessment of tumor response to targeted therapy.AJR Am J Roentgenol. 2010 Sep;195(3):W221-8.
    20729419
  • Ballen KK, Cutler C, Yeap BY, McAfee SL, Dey BR, Attar EC, Chen YB, Haspel RL, Liney D, Koreth J, Ho V, Alyea EP, Soiffer RJ, Spitzer TR, Antin JH.Donor Derived Second Hematologic Malignancies after Cord Blood Transplantation.Biol Blood Marrow Transplant. 2010 Jul;16(7):1025-31.
    20178854
  • Sholl LM, Barletta JA, Yeap BY, Chirieac LR, Hornick JL.Sox2 protein expression is an independent poor prognostic indicator in stage I lung adenocarcinoma.Am J Surg Pathol. 2010 Aug;34(8):1193-8.
    20631605
  • Benedettini E, Sholl LM, Peyton M, Reilly J, Ware C, Davis L, Vena N, Bailey D, Yeap BY, Fiorentino M, Ligon AH, Pan BS, Richon V, Minna JD, Gazdar AF, Draetta G, Bosari S, Chirieac LR, Lutterbach B, Loda M.Met Activation in Non-Small Cell Lung Cancer Is Associated with de Novo Resistance to EGFR Inhibitors and the Development of Brain Metastasis.Am J Pathol. 2010 Jul;177(1):415-23.
    20489150
  • Yeo WL, Riely GJ, Yeap BY, Lau MW, Warner JL, Bodio K, Huberman MS, Kris MG, Tenen DG, Pao W, Kobayashi S, Costa DB.Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.J Thorac Oncol. 2010 Jul;5(7):1048-53.
    20512075
  • Sholl LM, Xiao Y, Joshi V, Yeap BY, Cioffredi LA, Jackman DM, Lee C, Jänne PA, Lindeman NI.EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry.Am J Clin Pathol. 2010 Jun;133(6):922-34.
    20472851
  • Duran-Struuck R, Cho PS, Teague AG, Fishman B, Fishman AS, Hanekamp JS, Moran SG, Wikiel KJ, Ferguson KK, Lo DP, Duggan M, Arn JS, Billiter B, Horner B, Houser S, Yeap BY, Westmoreland SV, Spitzer TR, McMorrow IM, Sachs DH, Bronson RT, Huang CA.Myelogenous leukemia in adult inbred MHC-defined miniature swine: A model for human myeloid leukemias.Veterinary Immunology And Immunopathology. 2010 Jun 15;135(3-4):243-56.
    20079939
  • Hartman ML, Esposito JM, Yeap BY, Sugarbaker DJ.Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma.J Thorac Cardiovasc Surg. 2010 May;139(5):1233-40.
    19853261
  • Richards WG, Godleski JJ, Yeap BY, Corson JM, Chirieac LR, Zellos L, Mujoomdar A, Jaklitsch MT, Bueno R, Sugarbaker DJ.Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases.Cancer. 2010 Mar 15;116(6):1510-7.
    20108310
  • Barletta JA,Perner S,Iafrate AJ,Yeap BY,Weir BA,Johnson LA,Johnson BE,Meyerson M,Rubin MA,Travis WD,Loda M,Chirieac LR.Clinical Significance of TTF-1 Protein Expression and TTF-1 Gene Amplification in Lung Adenocarcinoma.J Cell Mol Med. 2009 Aug;13(8B):1977-86.
    19040416
  • Turke AB, Zejnullahu K, Wu YL, Song Y, Dias-Santagata D, Lifshits E, Toschi L, Rogers A, Mok T, Sequist L, Lindeman NI, Murphy C, Akhavanfard S, Yeap BY, Xiao Y, Capelletti M, Iafrate AJ, Lee C, Christensen JG, Engelman JA, Jänne PA.Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC.Cancer Cell. 2010 Jan 19;17(1):77-88.
    20129249
  • Barletta JA, Yeap BY, Chirieac LR.Prognostic significance of grading in lung adenocarcinoma.Cancer. 2010 Feb 1;116(3):659-69.
    20014400
  • Faber AC, Li D, Song Y, Liang MC, Yeap BY, Bronson RT, Lifshits E, Chen Z, Maira SM, García-Echeverría C, Wong KK, Engelman JA.Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition.Proc Natl Acad Sci U S A. 2009 Nov 17;106(46):19503-8.
    19850869
  • Sholl LM, Yeap BY, Iafrate AJ, Holmes-Tisch AJ, Chou YP, Wu MT, Goan YG, Su L, Benedettini E, Yu J, Loda M, Jänne PA, Christiani DC, Chirieac LR.Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers.Cancer Res. 2009 Nov 1;69(21):8341-8.
    19826035
  • Sholl LM, Yeap BY, Iafrate AJ, Holmes-Tisch AJ, Chou YP, Wu MT, Goan YG, Su L, Benedettini E, Yu J, Loda M, Jänne PA, Christiani DC, Chirieac LR.Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokers.Cancer Res. 2009 Nov 1;69(21):8341-8348.
  • Shaw AT, Yeap BY, Mino-Kenudson M, Digumarthy SR, Costa DB, Heist RS, Solomon B, Stubbs H, Admane S, McDermott U, Settleman J, Kobayashi S, Mark EJ, Rodig SJ, Chirieac LR, Kwak EL, Lynch TJ, Iafrate AJ.Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Who Harbor EML4-ALK.J Clin Oncol. 2009 Sep 10;27(26):4247-53.
    19667264
  • Pirl WF, Greer J, Temel JS, Yeap BY, Gilman SE.Major Depressive Disorder in Long-Term Cancer Survivors: Analysis of the National Comorbidity Survey Replication.J Clin Oncol. 2009 Sep 1;27(25):4130-4.
    19636024
  • Rodig SJ, Mino-Kenudson M, Dacic S, Yeap BY, Shaw A, Barletta JA, Stubbs H, Law K, Lindeman N, Mark E, Janne PA, Lynch T, Johnson BE, Iafrate AJ, Chirieac LR.Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.Clin Cancer Res. 2009 Aug 15;15(16):5216-23.
    19671850
  • Jackman DM, Miller VA, Cioffredi LA, Yeap BY, Jänne PA, Riely GJ, Ruiz MG, Giaccone G, Sequist LV, Johnson BE.Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials.Clin Cancer Res. 2009 Aug 15;15(16):5267-73.
    19671843
  • Hattangadi JA, Hong TS, Yeap BY, Mamon HJ.Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma.Cancer. 2009 Aug 15;115(16):3640-50.
    19514088
  • Tilleman TR, Richards WG, Zellos L, Johnson BE, Jaklitsch MT, Mueller J, Yeap BY, Mujoomdar AA, Ducko CT, Bueno R, Sugarbaker DJ.Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study.J Thorac Cardiovasc Surg. 2009 Aug;138(2):405-11.
    19619785
  • Naumov GN,Nilsson MB,Cascone T,Briggs A,Straume O,Akslen LA,Lifshits E,Byers LA,Xu L,Wu HK,Janne P,Kobayashi S,Halmos B,Tenen D,Tang XM,Engelman J,Yeap B,Folkman J,Johnson BE,Heymach JV.Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance.Clin Cancer Res. 2009 May 15;15(10):3484-94.
    19447865
  • Gordon GJ,Dong L,Yeap BY,Richards WG,Glickman JN,Edenfield H,Mani M,Colquitt R,Maulik G,Van Oss B,Sugarbaker DJ,Bueno R.Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma.Journal of the National Cancer Institute. 2009 May 6;101(9):678-86.
    19401544
  • Kuang Y,Rogers A,Yeap BY,Wang L,Makrigiorgos M,Vetrand K,Thiede S,Distel RJ,Janne PA.Noninvasive detection of EGFR T790M in gefitinib or erlotinib resistant non-small cell lung cancer.Clin Cancer Res. 2009 Apr 15;15(8):2630-6.
    19351754
  • Wang H,Asavaroengchai W,Yeap BY,Wang MG,Wang S,Sykes M,Yang YG.Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury.Blood. 2009 Apr 9;113(15):3612-9.
    19211507
  • Delaney M,Cutler CS,Haspel RL,Yeap BY,McAfee SL,Dey BR,Attar E,Kao G,Alyea EP,Koreth J,Ho VT,Saidman S,Liney D,Sese D,Soiffer RJ,Spitzer TR,Antin JH,Ballen KK.High-resolution HLA matching in double-umbilical-cord-blood reduced-intensity transplantation in adults.Transfusion. 2009 May;49(5):995-1002.
    19159415
  • Yusuf RZ, Dey B, Yeap BY, McAfee S, Attar E, Sepe PS, Dube C, Spitzer TR, Ballen KK.Autologous SCT with a dose-reduced BU and CY regimen in older patients with non-Hodgkin's lymphoma.Bone Marrow Transplant. 2009 Jan;43(1):37-42.
    18794868
  • DeLaney TF,Liebsch NJ,Pedlow FX,Adams J,Dean S,Yeap BY,McManus P,Rosenberg AE,Nielsen GP,Harmon DC,Spiro IJ,Raskin KA,Suit HD,Yoon SS,Hornicek FJ.Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas.Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):732-9.
    19095372
  • Costa DB,Nguyen KS,Cho BC,Sequist LV,Jackman DM,Riely GJ,Yeap BY,Halmos B,Kim JH,Janne PA,Huberman MS,Pao W,Tenen DG,Kobayashi S.Effects of erlotinib in EGFR mutated non-small cell lung cancers with resistance to gefitinib.Clin Cancer Res. 2008 Nov 1;14(21):7060-7.
    18981003
  • Saad AG,Yeap BY,Thunnissen FB,Pinkus GS,Pinkus JL,Loda M,Sugarbaker DJ,Johnson BE,Chirieac LR.Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma.Cancer. 2008 Oct 15;113(8):2129-38.
    18720359
  • Winkfield KM,Linsenmeier C,Yock TI,Grant PE,Yeap BY,Butler WE,Tarbell NJ.Surveillance of craniopharyngioma cyst growth in children treated with proton radiotherapy.Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):716-21.
    18676089
  • Koivunen JP, Kim J, Lee J, Rogers AM, Park JO, Zhao X, Naoki K, Okamoto I, Nakagawa K, Yeap BY, Meyerson M, Wong KK, Richards WG, Sugarbaker DJ, Johnson BE, Jänne PA.Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients.Br J Cancer. 2008 Jul 22;99(2):245-52.
    18594528
  • Kerber RA,Amos CI,Yeap BY,Finkelstein DM,Thomas DC.Design considerations in a sib-pair study of linkage for susceptibility loci in cancer.BMC Med Genet. 2008;9:64.
    18616822
  • Macdonald SM, Safai S, Trofimov A, Wolfgang J, Fullerton B, Yeap BY, Bortfeld T, Tarbell NJ, Yock T.Proton Radiotherapy for Childhood Ependymoma: Initial Clinical Outcomes and Dose Comparisons.Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):979-86.
    18325681
  • Haspel RL, Kao G, Yeap BY, Cutler C, Soiffer RJ, Alyea EP, Ho VT, Koreth J, Dey BR, McAfee SL, Attar EC, Spitzer T, Antin JH, Ballen KK.Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation.Bone Marrow Transplant. 2008 Mar;41(6):523-9.
    18037942
  • Liu G, Gurubhagavatula S, Zhou W, Wang Z, Yeap BY, Asomaning K, Su L, Heist R, Lynch TJ, Christiani DC.Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib.Pharmacogenomics J. 2008 Apr;8(2):129-38.
    17375033
  • Allen AM, Mentzer SJ, Yeap BY, Soto R, Baldini EH, Rabin MS, Sugarbaker DJ, Bueno R.Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience.Cancer. 2008 Mar 1;112(5):1106-13.
    18286507
  • Gordon GJ, Mani M, Maulik G, Mukhopadhyay L, Yeap BY, Kindler HL, Salgia R, Sugarbaker DJ, Bueno R.Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.Cancer Chemother Pharmacol. 2008 Apr;61(4):549-58.
    17522864
  • Richards W, Van Oss S, Glickman J, Chirieac L, Yeap B, Dong L, Gordon G, Mercer H, Gill K, Imrich A, Bueno R, Sugarbaker D.A microaliquoting technique for precise histological annotation and optimization of cell content in frozen tissue specimens.Biotech Histochem. 2007 Oct 3:1-9.
    17917854
  • Jnne PA, von Pawel J, Cohen RB, Crino L, Butts CA, Olson SS, Eiseman IA, Chiappori AA, Yeap BY, Lenehan PF, Dasse K, Sheeran M, Bonomi PD.Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer.J Clin Oncol. 2007 Sep 1;25(25):3936-44.
    17761977
  • Ballen KK, Shpall EJ, Avigan D, Yeap BY, Fisher DC, McDermott K, Dey BR, Attar E, McAfee S, Konopleva M, Antin JH, Spitzer TR.Phase I trial of parathyroid hormone to facilitate stem cell mobilization.Biol Blood Marrow Transplant. 2007 Jul;13(7):838-43.
    17580262
  • Liu G, Zhou W, Yeap BY, Su L, Wain JC, Poneros JM, Nishioka NS, Lynch TJ, Christiani DC.XRCC1 and XPD Polymorphisms and Esophageal Adenocarcinoma Risk.Carcinogenesis. 2007 Jun;28(6):1254-8.
    17264068
  • Linden PA, Yeap BY, Chang MY, Henderson WG, Jaklitsch MT, Khuri S, Sugarbaker DJ, Bueno R.Morbidity of lung resection after prior lobectomy: results from the Veterans Affairs National Surgical Quality Improvement Program.Ann Thorac Surg. 2007 Feb;83(2):425-31; discussion 432.
    17257965
  • Gordon GJ, Mani M, Mukhopadhyay L, Dong L, Edenfield HR, Glickman JN, Yeap BY, Sugarbaker DJ, Bueno R.Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.J Pathol. 2007 Mar;211(4):447-54.
    17253596
  • Gordon GJ, Mani M, Mukhopadhyay L, Dong L, Yeap BY, Sugarbaker DJ, Bueno R.Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.J Pathol. 2007 Mar;211(4):439-46.
    17253597
  • Jackman DM, Yeap BY, Lindeman NI, Fidias P, Rabin MS, Temel J, Skarin AT, Meyerson M, Holmes AJ, Borras AM, Freidlin B, Ostler PA, Lucca J, Lynch TJ, Johnson BE, Jnne PA.Phase II clinical trial of chemotherapy-naive patients > or = 70 years of age treated with erlotinib for advanced non-small-cell lung cancer.J Clin Oncol. 2007 Mar 1;25(7):760-6.
    17228019
  • Ballen KK, Spitzer TR, Yeap BY, McAfee S, Dey BR, Attar E, Haspel R, Kao G, Liney D, Alyea E, Lee S, Cutler C, Ho V, Soiffer R, Antin JH.Double unrelated reduced-intensity umbilical cord blood transplantation in adults.Biol Blood Marrow Transplant. 2007 Jan;13(1):82-9.
    17222756
  • Engelman JA, Mukohara T, Zejnullahu K, Lifshits E, Borrs AM, Gale CM, Naumov GN, Yeap BY, Jarrell E, Sun J, Tracy S, Zhao X, Heymach JV, Johnson BE, Cantley LC, Jnne PA.Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR -amplified lung cancer.J Clin Invest. 2006 Oct;116(10):2695-706.
    16906227
  • Gordon GJ, Deters LA, Nitz MD, Lieberman BC, Yeap BY, Bueno R.Differential diagnosis of solitary lung nodules with gene expression ratios.J Thorac Cardiovasc Surg. 2006 Sep;132(3):621-7.
    16935118
  • Jackman DM, Yeap BY, Sequist LV, Lindeman N, Holmes AJ, Joshi VA, Bell DW, Huberman MS, Halmos B, Rabin MS, Haber DA, Lynch TJ, Meyerson M, Johnson BE, Jnne PA.Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.Clin Cancer Res. 2006 Jul 1;12(13):3908-14.
    16818686
  • Richards WG, Zellos L, Bueno R, Jaklitsch MT, Jnne PA, Chirieac LR, Yeap BY, Dekkers RJ, Hartigan PM, Capalbo L, Sugarbaker DJ.Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.J Clin Oncol. 2006 Apr 1;24(10):1561-7.
    16575008
  • Linden PA, Gilbert RJ, Yeap BY, Boyle K, Deykin A, Jaklitsch MT, Sugarbaker DJ, Bueno R.Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation.J Thorac Cardiovasc Surg. 2006 Feb;131(2):438-46.
    16434276
  • Mukohara T, Engelman JA, Hanna NH, Yeap BY, Kobayashi S, Lindeman N, Halmos B, Pearlberg J, Tsuchihashi Z, Cantley LC, Tenen DG, Johnson BE, Jnne PA.Differential effects of gefitinib and cetuximab on non-small-cell lung cancers bearing epidermal growth factor receptor mutations.J Natl Cancer Inst. 2005 Aug 17;97(16):1185-94.
    16106023
  • Gordon GJ, Rockwell GN, Godfrey PA, Jensen RV, Glickman JN, Yeap BY, Richards WG, Sugarbaker DJ, Bueno R.Validation of genomics-based prognostic tests in malignant pleural mesothelioma.Clin Cancer Res. 2005 Jun 15;11(12):4406-14.
    15958625
  • Mamon HJ, Yeap BY, Jnne PA, Reblando J, Shrager S, Jaklitsch MT, Mentzer S, Lukanich JM, Sugarbaker DJ, Baldini EH, Berman S, Skarin A, Bueno R.High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.J Clin Oncol. 2005 Mar 1;23(7):1530-7.
    15735128
  • Ballen KK, Becker PS, Yeap BY, Matthews B, Henry DH, Ford PA.Autologous stem-cell transplantation can be performed safely without the use of blood-product support.J Clin Oncol. 2004 Oct 15;22(20):4087-94.
    15353543
  • Jnne PA, Gurubhagavatula S, Yeap BY, Lucca J, Ostler P, Skarin AT, Fidias P, Lynch TJ, Johnson BE.Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, "Iressa") on an expanded access study.Lung Cancer. 2004 May;44(2):221-30.
    15084387
  • Daly A, McAfee S, Dey B, Colby C, Schulte L, Yeap B, Sackstein R, Tarbell NJ, Sachs D, Sykes M, Spitzer TR.Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants.Biol Blood Marrow Transplant. 2003 Jun;9(6):373-82.
    12813445
  • Gallagher RE, Yeap BY, Bi W, Livak KJ, Beaubier N, Rao S, Bloomfield CD, Appelbaum FR, Tallman MS, Slack JL, Willman CL.Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129.Blood. 2003 Apr 1;101(7):2521-8.
    12468436
  • Colby C, Koziol S, McAfee SL, Yeap B, Spitzer TR.High-dose carboplatin and regimen-related toxicity following autologous bone marrow transplant.Bone Marrow Transplant. 2002 Mar;29(6):467-72.
    11960264
  • Pierie JP, Choudry U, Muzikansky A, Yeap BY, Souba WW, Ott MJ.The effect of surgery and grade on outcome of gastrointestinal stromal tumors.Arch Surg. 2001 Apr;136(4):383-9.
    11296107
  • Yeap BY, Davidian M.Robust two-stage estimation in hierarchical nonlinear models.Biometrics. 2001 Mar;57(1):266-72.
    11252609